Clinical trial
A PhaseⅡ Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 Years
NCT02710851 is registered in ClinicalTrials.gov with Jun Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A PhaseⅡ Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 Years
- Lead sponsor
- Jun Zhang
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 24, 2016
- Completion date
- December 30, 2023
- Enrollment
- 640 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.